Why Choose Australia for Your Clinical Trials?

Why Choose Australia for Your Clinical Trials?

Explore Australia's clinical trial ecosystem, benefits, and Korean collaboration experiences at our workshop. Unlock medtech opportunities!

By MTPConnect

Date and time

Tuesday, May 7 · 3:15 - 5:30pm KST

Location

Conference room, 51st floor, Trade Tower

511 Gangnam-gu, Seoul 06164 Korea, Republic of

About this event

  • 2 hours 15 minutes

Join us for an insightful clinical trials workshop covering Medical Devices and Therapeutics while covering the comprehensive landscape of Australia's clinical trials, this workshop aims to engage a broad audience, particularly targeting the vibrant medtech sector. Learn why Australia is the preferred destination for clinical trials, explore the robust clinical trial ecosystem, and hear real-life experiences of Korean companies collaborating with Australia.

Key Highlights:

  • Why Choose Australia for Clinical Trials:
    Discover the unique advantages and incentives for conducting clinical trials in Australia, including streamlined regulatory processes, world-class research facilities, and access to a diverse patient population.
  • Australian Clinical Trial Ecosystem:
    Gain insights into the dynamic landscape of clinical trials in Australia, highlighting key players, regulatory requirements, and recent trends shaping the industry.
  • Overview of Clinical Trials:
    Get a comprehensive overview of the clinical trial process, from protocol development to data analysis, emphasizing best practices and regulatory compliance.
  • Clinical Trial Notification Scheme:
    Learn about Australia's Clinical Trial Notification (CTN) scheme, facilitating efficient approval processes for initiating clinical trials, and ensuring patient safety.
  • R&D Tax Incentive:
    Understand the Research and Development (R&D) Tax Incentive available in Australia, providing financial support for companies conducting clinical trials and other research activities.
  • Korean Experiences Working with Australia:
    Hear firsthand experiences from Korean companies that have successfully collaborated with Australian counterparts on clinical trials, sharing insights, challenges, and lessons learned.

Who Should Attend:

  • Medtech professionals and industry stakeholders
  • Clinical research organizations (CROs) and contract manufacturing organizations (CMOs)
  • Regulatory affairs professionals
  • Investors and funding agencies interested in healthcare innovation

Don't miss this opportunity to explore the immense potential of Australia's clinical trial ecosystem and forge valuable partnerships with leading industry players. Register now to secure your spot at this collaborative workshop, driving innovation and growth in the medtech sector.

Organized by

MTPConnect is Australia’s Life Sciences Innovation Accelerator – an independent, not-for-profit organisation formed by the Australian Government to champion the continuing growth of Australia's vibrant medical products sector. Forging stronger connections between research and industry to help maximise opportunities for Australians to not only make scientific and technological breakthroughs, but to see them developed through the proof-of-concept stage and successfully translated and commercialised. In this way, MTPConnect is building a more resilient and competitive medical products sector.